Next, we observed MOGAT3, but not MOGAT1 or MOGAT2, markedly elevated in resistant PDX tumors and RKO EC-R cells compared with respective sensitive tumor cells (Figure 3A and Supplemental Figure 3C). The gene discussed is MOGAT3; the disease is neoplasm.